Carl Zeiss Meditec (AFX) Stock Statistics & Valuation Metrics

Carl Zeiss Meditec has a market cap or net worth of CHF 2.89B. The enterprise value is CHF 2.72B.

Market Cap

CHF 2.89B

Enterprise Value

CHF 2.72B

Carl Zeiss Meditec has 89,440,570 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding

89,440,570

Owned by Insiders

―

Owned by Institutions

4.90%

Carl Zeiss Meditec’s return on equity (ROE) is 0.07 and return on invested capital (ROIC) is 5.50%.

Return on Equity (ROE)

0.07

Return on Assets (ROA)

0.04

Return on Invested Capital (ROIC)

5.50%

Return on Capital Employed (ROCE)

0.08

Revenue Per Employee

385.14K

Profits Per Employee

24.41K

Employee Count

5,784

Asset Turnover

0.64

Inventory Turnover

2.12

The current PE Ratio of Carl Zeiss Meditec is 20.95. Carl Zeiss Meditec’s PEG ratio is -6.04.

PE Ratio

20.95

PS Ratio

1.16

PB Ratio

1.43

Price to FCF

11.24

Price to Operating Cash Flow

10.05

PEG Ratio

-6.04

In the last 12 months, Carl Zeiss Meditec had revenue of 2.23B and earned 141.21M in profits. Earnings per share was 1.61.

Revenue

2.23B

Gross Profit

1.18B

Operating Income

223.32M

Pretax Income

193.89M

Net Income

141.21M

EBITDA

346.89M

Earnings Per Share (EPS)

1.61

In the last 12 months, operating cash flow was 300.27M and capital expenditures -27.76M, giving a free cash flow of 272.51M billion.

Operating Cash Flow

300.27M

Free Cash Flow

272.51M

Free Cash Flow per Share

3.16

Carl Zeiss Meditec pays an annual dividend of ―, resulting in a dividend yield of 1.52%

Dividend Per Share

―

Dividend Yield

1.52%

Payout Ratio

N/A

Free Cash Flow Yield

8.90%

Earnings Yield

3.86%

Beta

0.18

52-Week Price Change

-81.65%

50-Day Moving Average

29.86

200-Day Moving Average

36.20

Relative Strength Index (RSI)

92.05

Average Volume (3m)

550

Carl Zeiss Meditec upcoming earnings date is Dec 10, 2026, Before Open (Not Confirmed).

Last Earnings Date

Aug 06, 2026

Next Earnings Date

Dec 10, 2026

Ex-Dividend Date

―

Carl Zeiss Meditec as a current ratio of 2.35, with Debt / Equity ratio of 28.70%

Current Ratio

2.35

Quick Ratio

1.44

Debt to Market Cap

0.14

Net Debt to EBITDA

1.67

Interest Coverage Ratio

8.39

In the past 12 months, Carl Zeiss Meditec has paid 51.55M in taxes.

Income Tax

51.55M

Effective Tax Rate

0.27

Carl Zeiss Meditec EV to EBITDA ratio is 9.26, with an EV/FCF ratio of 11.24.

EV to Sales

1.16

EV to EBITDA

9.26

EV to Free Cash Flow

11.24

EV to Operating Cash Flow

10.20

Carl Zeiss Meditec has CHF 23.90M in cash and marketable securities with CHF 0.00 in debt, giving a net cash position of CHF 23.90M billion.

Cash & Marketable Securities

CHF 23.90M

Total Debt

CHF 0.00

Net Cash

CHF 23.90M

Net Cash Per Share

CHF 0.27

Tangible Book Value Per Share

CHF 24.43

Gross margin is 51.04%, with operating margin of 6.42%, and net profit margin of 4.40%.

Gross Margin

51.04%

Operating Margin

6.42%

Pretax Margin

5.71%

Net Profit Margin

4.40%

EBITDA Margin

12.49%

EBIT Margin

6.60%

The average price target for Carl Zeiss Meditec is CHF 23.46, which is 11.43% higher than the current price. The consensus rating is Moderate Sell

Price Target

CHF 23.46

Price Target Upside

26.79% Downside

Analyst Consensus

Moderate Sell

Analyst Count

10

Revenue Growth Forecast

-2.34%

EPS Growth Forecast

-40.09%

Smart Score

7

AI Score

―